Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China · Delayed Price · Currency is CNY 30.59
-0.22 (-0.71%)
Aug 21, 2026, 3:00 PM CST
SHA:603392 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,377 | 2,435 | 2,388 | 3,819 | 5,193 | 1,416 |
Short-Term Investments | 358 | 1,168 | 480 | - | - | 200 |
Trading Asset Securities | 1,563 | 1,447 | 2,510 | 2,055 | 2,009 | 40.39 |
Cash & Short-Term Investments | 4,298 | 5,050 | 5,378 | 5,874 | 7,201 | 1,656 |
Cash Growth | -14.18% | -6.10% | -8.44% | -18.43% | 334.83% | 103.56% |
Accounts Receivable | 1,538 | 1,638 | 2,064 | 2,999 | 3,960 | 2,277 |
Other Receivables | 45.36 | 97.64 | 35.96 | 48.71 | 5.15 | 12.45 |
Receivables | 1,585 | 1,738 | 2,104 | 3,053 | 3,970 | 2,292 |
Inventory | 773.01 | 702.08 | 863.19 | 905.48 | 869.14 | 593.17 |
Other Current Assets | 87.01 | 36.57 | 29.44 | 469.42 | 139.4 | 105.2 |
Total Current Assets | 6,744 | 7,526 | 8,375 | 10,302 | 12,180 | 4,647 |
Property, Plant & Equipment | 3,414 | 3,518 | 3,538 | 2,641 | 2,235 | 1,703 |
Long-Term Investments | 1,772 | 1,292 | 1,362 | 12.01 | 911.3 | 61.3 |
Other Intangible Assets | 767.48 | 797.38 | 512.46 | 508.28 | 292.5 | 289.92 |
Long-Term Deferred Tax Assets | 361.57 | 338.18 | 243.33 | 157.95 | 66.01 | 68.97 |
Long-Term Deferred Charges | 355.6 | 292.39 | 363.85 | 214.29 | 172.37 | 27.18 |
Other Long-Term Assets | 292.73 | 280.67 | 294.67 | 1,879 | 372.3 | 249.09 |
Total Assets | 13,706 | 14,044 | 14,689 | 15,715 | 16,230 | 7,046 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 192.24 | 143.61 | 137.94 | 234.28 | 275.47 | 154.08 |
Accrued Expenses | 598.35 | 641.71 | 915.89 | 1,653 | 2,572 | 1,541 |
Short-Term Debt | 132.16 | 133.66 | 103.62 | 81.14 | 140.14 | 235.64 |
Current Portion of Long-Term Debt | 22.42 | 56.85 | 65.68 | 87.19 | 3.07 | - |
Current Portion of Leases | 24.2 | 19.52 | 38.43 | 13.3 | 13.73 | 13.93 |
Current Income Taxes Payable | 1.97 | 0.43 | 8.59 | 7.49 | 99.02 | 146.55 |
Current Unearned Revenue | 43.27 | 41.05 | 48.15 | 70.38 | 82.28 | 70.3 |
Other Current Liabilities | 579.32 | 765.4 | 693.76 | 523.42 | 299.34 | 204.64 |
Total Current Liabilities | 1,594 | 1,802 | 2,012 | 2,670 | 3,485 | 2,366 |
Long-Term Debt | 88.26 | 98.79 | 94.19 | 115.36 | 102.49 | 4.9 |
Long-Term Leases | 56.28 | 45.57 | 80.97 | 12.36 | 18.43 | 32.59 |
Long-Term Unearned Revenue | 67.27 | 64.39 | 54.2 | 33.65 | 41.37 | 76.44 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 17.15 | - |
Other Long-Term Liabilities | - | - | - | - | - | 3.8 |
Total Liabilities | 1,806 | 2,011 | 2,241 | 2,831 | 3,665 | 2,483 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,264 | 1,264 | 1,265 | 1,268 | 906.07 | 607.04 |
Additional Paid-In Capital | 3,048 | 3,048 | 3,139 | 3,312 | 3,729 | 445.83 |
Retained Earnings | 7,424 | 7,552 | 7,950 | 8,250 | 7,906 | 3,413 |
Treasury Stock | - | - | -92.17 | -129.42 | -200.17 | - |
Total Common Equity | 11,736 | 11,865 | 12,263 | 12,701 | 12,341 | 4,466 |
Minority Interest | 164.41 | 168.46 | 185.16 | 183.06 | 223.63 | 96.2 |
Shareholders' Equity | 11,901 | 12,033 | 12,448 | 12,884 | 12,565 | 4,562 |
Total Liabilities & Equity | 13,706 | 14,044 | 14,689 | 15,715 | 16,230 | 7,046 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 323.32 | 354.39 | 382.91 | 309.35 | 277.86 | 287.06 |
Net Cash (Debt) | 3,975 | 4,695 | 4,995 | 5,565 | 6,923 | 1,369 |
Net Cash Growth | -14.98% | -6.00% | -10.23% | -19.63% | 405.71% | 86.03% |
Net Cash Per Share | 3.13 | 3.65 | 3.76 | 4.42 | 5.54 | 1.11 |
Filing Date Shares Outstanding | 1,264 | 1,264 | 1,265 | 1,268 | 1,268 | 1,232 |
Total Common Shares Outstanding | 1,264 | 1,264 | 1,265 | 1,268 | 1,268 | 1,232 |
Working Capital | 5,150 | 5,724 | 6,363 | 7,632 | 8,695 | 2,281 |
Book Value Per Share | 9.28 | 9.38 | 9.69 | 10.01 | 9.73 | 3.62 |
Tangible Book Value | 10,969 | 11,067 | 11,750 | 12,192 | 12,049 | 4,176 |
Tangible Book Value Per Share | 8.68 | 8.75 | 9.29 | 9.61 | 9.50 | 3.39 |
Buildings | 1,612 | 1,557 | 779.65 | 724.87 | 628.89 | 392.67 |
Machinery | 2,181 | 2,127 | 1,764 | 1,510 | 1,185 | 666.87 |
Construction In Progress | 481.47 | 571.79 | 1,469 | 814.56 | 720.51 | 924.38 |